WAVE Life Sciences To Present At The SunTrust Robinson Humphrey 2016 Orphan Drug Day Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicine company focused on developing stereopure nucleic acid therapies to deliver new and exceptional treatment options for patients impacted by rare diseases, today announced that Paul Bolno, M.D., MBA, President and Chief Executive Officer, will present at the SunTrust Robinson Humphrey 2016 Orphan Drug Day on Tuesday, February 23, 2016 at the JW Marriott Essex House in New York, NY.

Back to news